Nursing home quality improvement project

Stop using the word antipsychotropic.

Begin using the metric system.

journal club announcement

Hi Tammy,

 

Here's the announcement for next week's journal club.

 

MARCH JOURNAL CLUB DETAILS:
Who:  Dr. Ana Caro.  With Dr. Tara Kaufman faculty supervisor.
When:  Tuesday, April 13 at 6:00 PM
Where:  Victoria's private room
RSVP to Tammy for attendance.

 

The article is "The role of calcium score and CT angiography in the medical management of patients with normal myocardial perfusion imaging".  It may be viewed on the web here:  http://bit.ly/aYy04N

 

Take care,

Mark

ABFM Certification Summer Exam Dates 2010

Dates: Certification and Recertification

Certification, Recertification and Sports Medicine Exams			2010
SUMMER EXAM 2010
Online Application Available	January 28
1st Deadline to Submit the Online Application ($1,250; No Late Fee Assessed)	February 28
2nd Deadline to Submit the Online Application ($1, 400)	March 31
3rd Deadline to Submit the Online Application ($1, 550)	April 30
Deadline for Priority Seating in Test Center Selection	May 12
4th Deadline to Submit the Online Application ($1, 700)	June 1
Deadline to Withdraw from the Examination without Cancellation fee	30 Days Prior to Scheduled Exam
Final Deadline to Submit the Online Application ($1,850)	June 15
Deadline to Submit Special Testing Accommodations Documentation	June 15
Deadline to Clear all Deficiencies	June 24
Deadline to Make Official Name Change with the ABFM for Examination	June 24
All Family Medicine Residency Training Must Be Completed (Primary Certification Candidates only)	June 30
Deadline to Provide ABFM Residency Training Completion Letter (Primary Certification Candidates only)	June 30
All Sports Medicine Fellowship Training Must Be Completed (Sports Certification Candidates only)	July 31
Deadline to Provide Sports Medicine Fellowship Training Completion Letter (Sports Certification Candidates only)	July 31
Deadline to Select Testing Date/Location	July 1
Deadline to Change Testing Date/Location	48 hours prior to scheduled exam
Deadline to Withdraw from Examination	5 days prior to scheduled exam
Examination Dates	July 12, 13, 14, 15, 17, 19, 20, 21, 22, 23, 24

Physician Rotation at MDH

 

The close collaboration between the Minnesota health care community and the Minnesota Department Health has been critical to the many successes in public health that Minnesota has experienced. In order to expand and improve this close relationship, MDH offers a two-day rotation for physicians-in-training with the goal of improving knowledge and communication between the health care community and MDH.  It is about 10 hours split between a Monday and Friday and offered about every 4 weeks. Upcoming dates for this academic year are below.

 

Content experts predominantly in the Infectious Disease Section and the Public Health Laboratory cover topics on an individual or small group basis including foodborne disease, zoonoses, vector-borne disease, infection prevention and control, refugee health, tuberculosis, immunizations, HIV/STD’s, laboratory and molecular epidemiology, and hot topics such as H1N1 Novel influenza among others.

 

Content is targeted toward residents but interested medical students would also be considered. If you have someone interested or have further questions about the rotation please let me know.

 

Please feel free to forward this to others within your program as well as others outside of your program who might be interested.

 

Minnesota Department of Health
Infectious Disease Epidemiology Prevention and Control
 

Springboard message [asthma and beta blockers]

Today's Springboard covers long acting beta agonists and avoiding their unnecessary use in asthmatics.
http://content.nejm.org/cgi/content/full/362/13/1169

Specific Label Changes for Long-Acting Beta-Agonists (LABAs).
1. Contraindicate the use of LABAs for asthma in patients of all ages without concomitant use of an asthma-controller medication such as an inhaled corticosteroid.

2. Stop use of the LABA, if possible, once asthma control is achieved and maintain the use of an asthma-controller medication, such as an inhaled corticosteroid.

3. Recommend against LABA use in patients whose asthma is adequately controlled with a low- or medium-dose inhaled corticosteroid.

4. Recommend that a fixed-dose combination product containing a LABA and an inhaled corticosteroid be used to ensure compliance with concomitant therapy in pediatric and adolescent patients who require the addition of a LABA to an inhaled corticosteroid.|

As we begin to increase our involvement in medical school education, I would like to make you aware of a program that helps people initiate programs

http://www.stfm.org/conferences/mseinstitute/index.cfm

Have a good week
John